# Topical Tacrolimus for Breast Cancer-related Lymphedema

> **NCT06306274** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Odense University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06306274
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-09
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306274, "Topical Tacrolimus for Breast Cancer-related Lymphedema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06306274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*